补肾化瘀法治疗良性前列腺增生症的临床研究

目的 观察补肾化瘀汤治疗前列腺增生症（BPH）患者的临床疗效.方法 采用随机对照法将80例患者分为治疗组（补肾化瘀汤）和对照组（西药：舍尼通）,各40例.行3个疗程（3个月）的治疗.记录国际前列腺症状评分（IPSS）、最大尿流率、前列腺体积、血清胰岛素样生长因子1（IGF-1）的变化,统计分析两组病例治疗前后变化.结果 治疗组的IPSS为（8.35±5.56）,最大尿流率为（14.52±3.56） ml/s,前列腺体积为（32.52±7.56） cm3,IGF-1为（268.31±16.35）μg/L,均较治疗前有显著性差异,差异具有统计学意义（P＜0.05）,而治疗组的IPSS、最大尿流率,前列腺体积,IGF-1与对照组比较,差异具有统计学意义（P＜0.05）.结论 补肾化瘀汤能够有效地改善前列腺增生症临床症状.

Bushen Huayu Tang for benign prostatic hyperplasia

Objective To observe the efficacy of Bushen Huayu Tang for patients with benign prostate hyperplasia. Methods 80 patients were randomly divided into a treatment group, 40 cases, treated with Bushen Huayu Tang, and a control group, 40 cases, treated with Cernihon. Both groups were treated 3 treatment courses for 3 months. The International Prostate Symptom Score （IPSS）, maximum urinary flow rate, prostate volume, and serum insulin-like growth factor 1 （IGF-1） were recorded before and after the treatment. And their changes of the results in the two groups were statistically analyzed before and after the treatment. Results After the treatment, the IPSS was （8.35 ± 5.56）, the maximum urinary flow rate （14.52 ± 3.56） ml/s, the prostate volume （32.52 ± 7.56） em3, and the serum IGF-1 （268.31 ± 16.35）μg/L in the treatment group, which were better than those before the treatment and those of the control group, with statistical differences （P 〈0.05）. Conclusion Bushen Huayu Tang for benign prostatic hyperplasia is effective.